reduce insulin dose when starting glp-1 receptor agonist Algorithm for titration in T2DM. TDD, total daily dose; Is GLP-1 the Same as
Description
So, typically the more effective the medication, the more likely the risk of adverse events
The GH/IGF1 Axis and Signaling Pathways in the Muscle and Bone: Mechanisms Underlying Age-Related Skeletal Muscle Wasting and Osteoporosis
For insurers, the elusiveness of short-term savings matter, because so many enrollees churn through different health insurers over time
Success will depend on how Novo optimises use and manages competitive pressure
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial
